C. D. Arnett

发表

Cryogenic quality meter final report

C. D. Arnett, H. D. Burke, A. M. Payne, 1964 .

Program plan for earth-orbital low g heat transfer and fluid mechanics experiments

C. D. Arnett, M. E. Nein, 1966 .

America's Lunar Roving Vehicle

C. D. Arnett, W. R. Adams, S. F. Morea, 1971 .

Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET.

C. D. Arnett, A. Wolf, J. Fowler, 1987, Science.

Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [18F]Fluorodeoxyglucose and [11C]Deoxyglucose

C. D. Arnett, A. Alavi, M. Reivich, 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

The utility of 1-[18F]fluoro-3-iodopropane for the synthesis of certain dopamine D-1 and benzodiazepine receptor radioligands.

C. D. Arnett, A. Wolf, C. Arnett, 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

No-carrier-added fluorine-18-labeled N-methylspiroperidol: synthesis and biodistribution in mice.

C. D. Arnett, A. Wolf, J. Fowler, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Syntheses and Specific Activity Determinations of No-Carrier-Added Fluorine-18-Labeled Neuroleptic Drugs

C. D. Arnett, A. Wolf, J. Fowler, 1985 .

A simple one-pot synthesis of cyclopropane [11C]carbonyl chloride. Synthesis and biodistribution of [11C]cyclorphan†

C. D. Arnett, A. Wolf, D. Hwang, 1986 .

Subclassification of alpha-adrenergic receptors by direct binding studies.

C. D. Arnett, R. Lefkowitz, C. Arnett, 1979, Biochemical pharmacology.

Turnover of Brain Monoamine Oxidase Measured In Vivo by Positron Emission Tomography Using l‐[11C]Deprenyl

C. D. Arnett, A. Wolf, B. Långström, 1987, Journal of neurochemistry.

Selective, irreversible in vivo binding of [11C]clorgyline and [11C]-L-deprenyl in mice: potential for measurement of functional monoamine oxidase activity in brain using positron emission tomography.

J S Fowler, R R MacGregor, C. D. Arnett, 1985, Biochemical pharmacology.

Comparison of Three 18F‐Labeled Butyrophenone Neuroleptic Drugs in the Baboon Using Positron Emission Tomography

C. D. Arnett, A. Wolf, J. Fowler, 1985, Journal of neurochemistry.

Species differences in [11C]clorgyline binding in brain.

C. D. Arnett, N. Volkow, J. Fowler, 2001, Nuclear medicine and biology.

Carbon-11 labelled ketamine-synthesis, distribution in mice and PET studies in baboons.

C. D. Arnett, A. Wolf, J. Fowler, 1997, Nuclear medicine and biology.

Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients

C. D. Arnett, J. Brodie, A. Wolf, 1988, Biological Psychiatry.

Brain α-adrenergic receptors: comparison of [3H]WB 4101 binding with norepinephrine-stimulated cyclic AMP accumulation in rat cerebral cortex

James N. Davis, C. D. Arnett, P. Skolnick, 1978, Brain Research.

Synthesis and biodistribution of 2-deoxy-2-[18F]fluoro-d-glucopyranosyl [18F]fluoride in mice

C. D. Arnett, A. Wolf, C. Arnett, 2004, European Journal of Nuclear Medicine.

Synthesis of 2-deoxy-2[82Br]bromo-d-mannose and related compounds and their biodistributions in mice

C. D. Arnett, A. Wolf, C. Arnett, 2004, European Journal of Nuclear Medicine.

Effects of DL-3-(5-benzimidazolyl)-2-methylalanine on brain and heart catecholamines-I. Depleting effects.

C. D. Arnett, C. Arnett, J. Wright, 1976, Biochemical pharmacology.

Specific Binding of [11C]Spiroperidol in Rat Brain In Vivo

C. D. Arnett, A. Wolf, J. Fowler, 1983, Journal of neurochemistry.

A direct comparison of the brain uptake and plasma clearance of N-[11C]methylspiroperidol and [18F]N-methylspiroperidol in baboon using PET.

C. D. Arnett, A. Wolf, B. Långström, 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

No-carrier-added (NCA) (+/-)-N-(3-[18F]fluoropropyl)-N-normetazocine-synthesis and PET studies in a baboon.

E. J. Simon, C. D. Arnett, A. Wolf, 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET.

C. D. Arnett, A. Wolf, J. Fowler, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11C]spiroperidol: synthesis, specific activity determination, and biodistribution in mice.

C. D. Arnett, A. Wolf, J. Fowler, 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Synthesis and adrenergic activity of benzimidazole bioisosteres of norepinephrine and isoproterenol.

C. D. Arnett, C D Arnett, J Wright, 1978, Journal of medicinal chemistry.

No-carrier-added N-(3-[18F]fluoropropyl)spiroperidol: biodistribution in mice and tomographic studies in a baboon.

C. D. Arnett, A. Wolf, C. Shiue, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain.

J S Fowler, C. D. Arnett, A. Wolf, 1985, Life sciences.

A comparison of the brain uptake of N-(cyclopropyl[11C]methyl)norbuprenorphine ([11C]buprenorphine) and N-(cyclopropyl[11C]methyl)nordiprenorphine ([11C]diprenorphine) in baboon using PET.

C. D. Arnett, A. Wolf, J. Fowler, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.